Gaskins Tammi L
- SEC CIK
- 0002061679
In the past year, 2 open-market sale filings worth $100.3K and no purchases.
Current role at each company
- IRWD Ironwood Pharmaceuticals IncChief Commercial Officeras of Mar 12, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $100.3K
- 2 filings
- Net
- −$100.3K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Gaskins Tammi L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 (view filing) | Feb 23-24 | 2 days | Gaskins Tammi LChief Commercial Officer | SSaleClass A Common Stock | −21.5K | $3.73 | −$80.3K | −9.1%213.7K after | 2 lots |
| Nov 19, 2025 (view filing) | Nov 17 | 2 days | Gaskins Tammi LChief Commercial Officer | SSaleClass A Common Stock | −6.02K | $3.32 | −$20.0K | −2.5%235.3K after | |
| Aug 13, 2025 (view filing) | Aug 11 | 2 days | Gaskins Tammi LChief Commercial Officer | SSaleClass A Common Stock | −1.32K | $0.84 | −$1.11K | −0.5%241.3K after | |
| May 20, 2025 (view filing) | May 16 | 4 days | Gaskins Tammi LChief Commercial Officer | SSaleClass A Common Stock | −2.56K | $0.58 | −$1.49K | −1.0%242.6K after |